-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WDv7ZnqEjGmgu1nkC02/BVG4eqpu70+GPvMsQsQz6dXJIXfczPz5gQjcmWhh6dtS Me0ltGLtK4wEdFi5875bAg== 0001058809-99-000008.txt : 19990309 0001058809-99-000008.hdr.sgml : 19990309 ACCESSION NUMBER: 0001058809-99-000008 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19961016 FILED AS OF DATE: 19990308 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOPHARMACEUTICS INC CENTRAL INDEX KEY: 0000733337 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133186327 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 001-09370 FILM NUMBER: 99559431 BUSINESS ADDRESS: STREET 1: 990 STATION RD CITY: BELLPORT STATE: NY ZIP: 11713 BUSINESS PHONE: 5162865800 MAIL ADDRESS: STREET 1: 990 STATION ROAD CITY: BELLPORT STATE: NY ZIP: 11713 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED GENERICS INC /NV/ DATE OF NAME CHANGE: 19880824 FORMER COMPANY: FORMER CONFORMED NAME: PATIENT MEDICAL SYSTEMS CORP DATE OF NAME CHANGE: 19880615 COMPANY DATA: COMPANY CONFORMED NAME: ROSEN JONATHAN CENTRAL INDEX KEY: 0001081252 STANDARD INDUSTRIAL CLASSIFICATION: [] DIRECTOR FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 520 S LUCERNE BLVD CITY: LOS ANGELES STATE: CA ZIP: 90020 MAIL ADDRESS: STREET 1: 520 S LUCERNE BLVD CITY: LOS ANGELES STATE: CA ZIP: 90020 3 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 3 Washington, D. C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 - ------------------------------------------------------------------------------------------------------------------------------------ |1 Name and Address of Reporting Person * |2 Date of Event |4 Issuer Name and Ticker/Trading Symbol|6 If Amendment, | | | Requiring | | Date of Original | | Rosen Jonathan | Statement |Biopharmaceutics, Inc. BOPM | (Month/Day/Year) | | (Last) (First) (Middle)| (Month/Day/Year) |---------------------------------------| | | | |5 Relationship of Reporting |-------------------| | c/o Biopharmaceutics, Inc. | 10/21/96 | Person(s) to Issuer |7 Individual or | | (Street1) |------------------| (Check all applicable) | Joint/Group Filing| | |3 IRS or Social | ( X ) Director ( ) 10% Owner| (Check Applicable)| | 990 Station Road | Security Number | | Form filed by: | | (Street2) | of Reporting | ( ) Officer ( ) Other | (X) One Reporting | | | Person | (Give Title below) (Specify below)| Person | | Bellport NY 11713 | (Voluntary) | | ( ) More Than One | | (City) (State) (Zip) | | | Reporting Person| |---------------------------------------------------|------------------|---------------------------------------|-------------------| Table I - Non-Derivative Securities Beneficially Owned - ------------------------------------------------------------------------------------------------------------------------------------ |1 Title of Security |2 Amount of Securities|3 Ownership: |4 Nature of Indirect Beneficial Ownership| | (Instruction 4) | Beneficially Owned | Direct (D) or| (Instruction 5) | | | (Instruction 4) | Indirect (I) | | | | | (Instr 5) | | - ------------------------------------------------------------------------------------------------------------------------------------ |Common Stock | 47,500| I |I/N/O a cmpany which is owned by Jonathan| | | | | Rosen's trust. | |--------------------------------------------------|----------------------|--------------|-----------------------------------------| | | | | | |--------------------------------------------------|----------------------|--------------|-----------------------------------------| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 5(b)(v). SEC 1473 (7-96)
FORM 3 (Continued) - ------------------------------------------------------------------------------------------------------------------------------------ Table II - Derivative Securities Beneficially Owned (Puts, Calls, Warrants, Options, Convertible Securities) - ------------------------------------------------------------------------------------------------------------------------------------ |1 Title of Derivative Security|2 Date |3 Title and Amount of |4 Conver- |5 Owner- |6 Nature of Indirect | | (Instruction 4) | Exercisable and | Securities Underlying | sion or | ship: | Beneficial Ownership| | | Expiration Date | Derivative Security | Exercise | Direct | (Instruction 5) | | | (Month/Day/Year) | (Instruction 4) | Price of | (D)or | | | |-------------------|------------------------------------| Deriv- | Indirect| | | | Date | Expira- | |Amount or| ative | (I) | | | | Exer- | tion | Title |Number | Security |(Instr 5)| | | | cisable | Date | |of Shares| | | | | | | | | | | | | |------------------------------|---------|---------|--------------------------|---------|----------|---------|---------------------| |None | | | | | | | | |------------------------------|---------|---------|--------------------------|---------|----------|---------|---------------------| Explanation of Responses: *Post split shares Jonathan Rosen 3/8/99 _____________________________________ ___________ ** Signature of Reporting Person Date ** Intentional misstatement or ommissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: Transmit one copy of this Form to EDGAR, using a typed signature. If space is insufficient, see Intruction 6 for procedure. SEC 1473 (7-96)
-----END PRIVACY-ENHANCED MESSAGE-----